Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7-day vs 14-day Bismuth Quadruple Therapy for Second-Line H. pylori Eradication
NCT00841854Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Jun 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pantoprazole, bismuth subsalicylate, metronidazole and tetracycline in Helicobacter pylori infection (2 arms), sponsored by Asan Medical Center. Primary endpoint: H. pylori Eradication Rate. Started Jun 2008; status: completed.
02
Drugs
pantoprazolebismuth subsalicylatemetronidazoletetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00841854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841854.